← Eichor
Condition: Ibd Unclassified Ibd U Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Ibd Unclassified Ibd U

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Switching to the IL-23 Inhibitor Guselkumab for People With Active IBD Who Previously Used Ustekinumab (SHIFT-IBD)
Phase N/A · 12 location(s) · TIDHI Innovation Inc. · NCT07245394Family Members At INcreased-risk for Developing Inflammatory Bowel Disease
Phase N/A · 1 location(s) · Massachusetts General Hospital · NCT06655415Therapeutic Drug Monitoring for Biological Therapy in Pediatric Inflammatory Bowel Disease
Phase N/A · 10 location(s) · Medical University Innsbruck · NCT06954311
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.